LONDON, May 28, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the market introduction and first commercial procedure of its Tula ...
The US Food and Drug Administration (FDA) has approved a new system for placement of tympanostomy tubes in children with otitis media that does not require general anesthesia. The Tubes Under Local ...
(RTTNews) - Medical technology business Smith+Nephew Plc (SN.L, SNN) Friday announced that it has acquired Tusker Medical, Inc., a California-based developer of the Tula System. The commercial terms ...
Smith & Nephew has acquired Tusker Medical, a company that has developed Tula, a system to treat recurrent or persistent ear infections. The London-based company kept the financial details of the deal ...
child ear exam The FDA has approved the Tubes Under Local Anesthesia (Tula) System (Tusker Medical) for the treatment of recurrent otitis media in patients ≥6 months of age. The Food and Drug ...
Smith+Nephew acquires Tusker Medical, Inc., developer of Tula, a new system for in-office delivery of ear tubes to treat recurrent or persistent ear infections The FDA-approved 'Breakthrough Device' ...
Menlo Park, Calif.-based startup Tusker Medical Inc. has received U.S. FDA approval to market its breakthrough-designated system for inserting tympanostomy tubes into the eardrum to treat recurrent ...
Menlo Park, Calif.-based startup Tusker Medical Inc. has received U.S. FDA approval to market its breakthrough-designated system for inserting tympanostomy tubes into the eardrum to treat recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results